98 related articles for article (PubMed ID: 9359947)
1. Erythromycin resistance in Finland declines after reduction in macrolide use.
Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
[No Abstract] [Full Text] [Related]
2. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
Seppälä H; Klaukka T; Vuopio-Varkila J; Muotiala A; Helenius H; Lager K; Huovinen P
N Engl J Med; 1997 Aug; 337(7):441-6. PubMed ID: 9250845
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
Viñado B; Domínguez J; Rodrigo C; Matas L
Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
[No Abstract] [Full Text] [Related]
4. Macrolide-resistant group a streptococcus--now in the United States.
Huovinen P
N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
[No Abstract] [Full Text] [Related]
5. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
[TBL] [Abstract][Full Text] [Related]
6. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
7. [Resistance to macrolides in Streptococcus pyogenes].
Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
[No Abstract] [Full Text] [Related]
8. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
9. Use of antimicrobial agents and drug resistance.
Swartz MN
N Engl J Med; 1997 Aug; 337(7):491-2. PubMed ID: 9250853
[No Abstract] [Full Text] [Related]
10. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
[No Abstract] [Full Text] [Related]
11. Erythromycin-resistant Streptococcus pyogenes in Argentina.
Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
13. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
Hsueh PR; Shyr JM; Wu JJ
Clin Infect Dis; 2005 Mar; 40(6):903-5. PubMed ID: 15736030
[No Abstract] [Full Text] [Related]
14. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
[No Abstract] [Full Text] [Related]
15. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
Hansman D
Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
[No Abstract] [Full Text] [Related]
16. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.
Seppälä H; Klaukka T; Lehtonen R; Nenonen E; Huovinen P
Clin Infect Dis; 1995 Dec; 21(6):1378-85. PubMed ID: 8749619
[TBL] [Abstract][Full Text] [Related]
17. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
18. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
Hardie R; Hardie RA
Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
[No Abstract] [Full Text] [Related]
19. Therapeutic implications of erythromycin resistance in group A streptococci.
Coonan K; Kaplan EL
Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
[No Abstract] [Full Text] [Related]
20. Value of throat cultures in adolescents taking daily antibiotics for acne.
Dajani AS
Pediatr Infect Dis J; 1994 Sep; 13(9):842-3. PubMed ID: 7808867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
